Cargando…

Editorial: Cardiac Hypertrophy: From Compensation to Decompensation and Pharmacological Interventions

Detalles Bibliográficos
Autores principales:	Liu, Ya, Chen, Xiongwen, Zhang, Hai-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107717/ https://www.ncbi.nlm.nih.gov/pubmed/33981242 http://dx.doi.org/10.3389/fphar.2021.665936

Ejemplares similares

Effect of Triptolide on Temporal Expression of Cell Cycle Regulators During Cardiac Hypertrophy
por: Li, Jing-Mei, et al.
Publicado: (2020)

Triptolide Upregulates Myocardial Forkhead Helix Transcription Factor p3 Expression and Attenuates Cardiac Hypertrophy
por: Ding, Yuan-Yuan, et al.
Publicado: (2016)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases
por: Wang, Xiaoping, et al.
Publicado: (2022)

Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis
por: Chen, Yan, et al.
Publicado: (2022)

Pharmacological suppression of Nedd4-2 rescues the reduction of Kv11.1 channels in pathological cardiac hypertrophy
por: Zhang, Hua, et al.
Publicado: (2022)

Network Pharmacology and In Vitro Experimental Verification Reveal the Mechanism of the Hirudin in Suppressing Myocardial Hypertrophy
por: Liu, Mengnan, et al.
Publicado: (2022)

Caffeine in liver diseases: Pharmacology and toxicology
por: Shan, Liang, et al.
Publicado: (2022)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Selective Inhibition of the Immunoproteasome β5i Prevents PTEN Degradation and Attenuates Cardiac Hypertrophy
por: Xie, Xin, et al.
Publicado: (2020)

Energy Metabolism in Exercise-Induced Physiologic Cardiac Hypertrophy
por: Xiang, Kefa, et al.
Publicado: (2020)

Editorial: Recent trends in pharmacological treatment of musculoskeletal disorders
por: Zong, Zhixian, et al.
Publicado: (2022)

Editorial: Purinergic Pharmacology
por: Ciruela, Francisco, et al.
Publicado: (2019)

Divergent Thyroid Hormone Levels in Plasma and Left Ventricle of the Heart in Compensated and Decompensated Cardiac Hypertrophy Induced by Chronic Adrenergic Stimulation in Mice
por: Simonides, Warner, et al.
Publicado: (2023)

Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway
por: Aiyasiding, Xiahenazi, et al.
Publicado: (2022)

Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling
por: Wu, Qing Q., et al.
Publicado: (2017)

Modeling the Transition From Decompensated to Pathological Hypertrophy
por: Pascual, Florencia, et al.
Publicado: (2018)

Editorial: Applications of Nanobiotechnology in Pharmacology
por: Qi, Baowen, et al.
Publicado: (2019)

Editorial: Innovation in ocular pharmacology
por: Gozzo, Lucia, et al.
Publicado: (2023)

Editorial: Evolution in respiratory pharmacology
por: Ruaro, Barbara, et al.
Publicado: (2023)

Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy
por: Zhen, Changlin, et al.
Publicado: (2023)

Editorial: Imaging Technology in Oncology Pharmacological Research
por: Zeng, Qi, et al.
Publicado: (2021)

Editorial: In vivo Imaging in Pharmacological Research
por: Beckmann, Nicolau, et al.
Publicado: (2017)

Editorial: Network Pharmacology and Traditional Medicine
por: Lai, Xinxing, et al.
Publicado: (2020)

Editorial: The Pharmacology of Kratom and Its Alkaloids
por: Grundmann, Oliver, et al.
Publicado: (2022)

Editorial: Insights in Inflammation Pharmacology: 2021
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Women in Inflammation Pharmacology: 2021
por: Patrignani, Paola
Publicado: (2022)

Editorial: Insights in renal pharmacology: 2021
por: Perico, Norberto, et al.
Publicado: (2022)

Editorial: Methods and applications in inflammation pharmacology
por: Schmidtchen, Artur, et al.
Publicado: (2022)

Editorial: Insights in respiratory pharmacology: 2021
por: Montuschi, Paolo, et al.
Publicado: (2022)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Editorial: Women in renal pharmacology: 2021
por: Benigni, Ariela, et al.
Publicado: (2022)

Editorial: Women in translational pharmacology: 2021
por: Vengeliene, Valentina, et al.
Publicado: (2023)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Editorial: Insights in inflammation pharmacology: 2022
por: Patrignani, Paola, et al.
Publicado: (2023)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Editorial: Global excellence in inflammation pharmacology
por: Saha, Sukanya, et al.
Publicado: (2023)

Editorial: Emerging talents in Frontiers in pharmacology: Gastrointestinal and hepatic pharmacology 2022
por: Grasa, Laura, et al.
Publicado: (2022)

Editorial: Emerging researchers in frontiers in pharmacology: obstetric and pediatric pharmacology 2022
por: Yang, Qiwei, et al.
Publicado: (2023)

Pharmacological Interventions for Bacterial Prostatitis
por: Xiong, Situ, et al.
Publicado: (2020)

Hydrogen (H(2)) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways
por: Zhang, Yaxing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3lek91a22mkji3cvkhvm1pa40k